FDA — authorised 5 March 2014
- Application: NDA022219
- Marketing authorisation holder: ENDO OPERATIONS
- Local brand name: AVEED
- Indication: INJECTABLE — INTRAMUSCULAR
- Status: approved
FDA authorised Aveed on 5 March 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 5 March 2014; FDA has authorised it.
ENDO OPERATIONS holds the US marketing authorisation.